文献速递妇科

腹腔镜子宫切除术路径、资源使用与结局:动力粉碎安全警告后的变化

Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.
PubMed 文献 · Obstet Gynecol · 2019-01-01

该回顾性研究分析2012-2016年美国外科医师学会国家外科质量改进计划中145,746例因良性指征行子宫切除术的女性,采用中断时间序列分析评估2014年4月FDA动力粉碎安全声明与腹腔镜子宫切除术利用、资源使用及30天手术结局的关联。结果显示警告后腹腔镜宫颈上子宫切除术使用显著降低(OR=0.49,95%CI 0.45-0.53),全腹腔镜子宫切除术未受影响(OR 1.01,95%CI 0.96-1.06),30天手术结局无显著变化。

要点

  • 警告后腹腔镜宫颈上子宫切除术使用显著降低(OR=0.49,95%CI 0.45-0.53)
  • 全腹腔镜子宫切除术使用未受显著影响(OR 1.01,95%CI 0.96-1.06)
  • 警告后30天手术结局无显著变化

核心结论

  • 腹腔镜宫颈上子宫切除术比例下降与动力粉碎安全警告相关,而其他腹腔镜子宫切除术比例继续上升。
  • 腹腔镜子宫切除术患者的结局无变化。

研究设计与样本

  • 回顾性分析2012-2016年美国外科医师学会国家外科质量改进计划数据,纳入145,746例因良性指征行子宫切除术的女性。
  • 采用中断时间序列分析评估FDA警告与腹腔镜子宫切除术利用及结局变化的关联。

主要发现

  • 调整患者特征与实践背景趋势后,警告后腹腔镜宫颈上子宫切除术使用较警告前显著降低(OR=0.49,95%CI 0.45-0.53)。
  • 全腹腔镜子宫切除术(含腹腔镜辅助阴式子宫切除术)使用未受影响(OR 1.01,95%CI 0.96-1.06)。
  • 警告后腹腔镜子宫切除术(宫颈上+全腹腔镜合计)使用经初期下降后随时间增加(每经过一个日历季度的调整OR=1.03,95%CI 1.02-1.03)。
  • 警告后腹腔镜宫颈上子宫切除术手术时间增加11.45分钟(95%CI 6.22-16.69)。
  • 全腹腔镜子宫切除术住院可能性的下降趋势减弱(每经过一个日历季度OR:警告前0.92,95%CI 0.91-0.93;警告后0.97,95%CI 0.97-0.98)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine changes in utilization of different types of laparoscopic hysterectomy, as well as their associated resource use and surgical outcomes, after the U.S. Food and Drug Administration (FDA) safety statement in April 2014 regarding power morcellation. METHODS: We retrospectively analyzed data from the 2012-2016 American College of Surgeons National Surgical Quality Improvement Program and identified 145,746 women undergoing hysterectomy for benign indications. We measured use of laparoscopic supracervical hysterectomy compared to total laparoscopic hysterectomy (including laparoscopic-assisted vaginal hysterectomy) in these patients, as well as operative time, surgical setting (inpatient vs outpatient), length of stay, and 30-day surgical outcomes (wound complication, medical complication, reoperation, and readmission). We used an interrupted time series analysis to examine the association between FDA warning and changes in utilization and outcomes of laparoscopic hysterectomy. RESULTS: After adjusting for patient characteristics and background trends in practice, use of laparoscopic supracervical hysterectomy was significantly lower in the postwarning than prewarning period (odds ratio [OR]=0.49, 95% CI 0.45-0.53), whereas use of total laparoscopic hysterectomy was not affected (OR 1.01, 95% CI 0.96-1.06). Overall, after an initial reduction, use of laparoscopic hysterectomy (laparoscopic supracervical hysterectomy and total laparoscopic hysterectomy combined) increased over time in the postwarning period (adjusted OR of utilization for each calendar quarter elapsed=1.03, 95% CI 1.02-1.03). After the FDA warning, operative time for laparoscopic supracervical hysterectomy increased by 11.45 minutes (95% CI 6.22-16.69), whereas the decreasing trend in the likelihood of inpatient stay for total laparoscopic hysterectomy was attenuated (OR for each calendar quarter elapsed=0.92 in prewarning period, 95% CI 0.91-0.93; and 0.97 in postwarning period, 95% CI 0.97-0.98). There was no significant change in 30-day surgical outcomes after the FDA warning. CONCLUSION: Rates of laparoscopic supracervical hysterectomy fell in association with power morcellation safety warnings, whereas rates of other laparoscopic hysterectomies continued to rise. There was no change in patient outcomes among laparoscopic hysterectomies.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Desai VB, Wright JD, Lin H, et al. Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning. Obstet Gynecol. 2019. PMID: 31348209. doi:10.1097/AOG.0000000000003375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。